{"id":"NCT04078126","sponsor":"AstraZeneca","briefTitle":"Study Comparing Dual Combination of Product (Budesonide and Formoterol) Given Via Two Different Inhalers. To See Which One Results in the Best Effect on Breathing.","officialTitle":"A Randomized, Open-Label, Two Period Crossover, Chronic Dosing, 1-Week, Pilot Study to Assess the Efficacy and Safety of Budesonide and Formoterol Fumarate Inhalation Aerosol Administered With a Spacer Compared With Symbicort® Turbuhaler® in Subjects With Severe to Very Severe Chronic Obstructive Pulmonary Disease and Low Peak Inspiratory Flow","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2019-09-10","primaryCompletion":"2020-12-30","completion":"2020-12-30","firstPosted":"2019-09-04","resultsPosted":"2022-03-18","lastUpdate":"2022-03-18"},"enrollment":35,"design":{"allocation":"RANDOMIZED","model":"CROSSOVER","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Chronic Obstructive Pulmonary Disease (COPD)"],"interventions":[{"type":"COMBINATION_PRODUCT","name":"BFF","otherNames":[]},{"type":"COMBINATION_PRODUCT","name":"Symbicort Turbuhaler","otherNames":[]}],"arms":[{"label":"Budesonide and formoterol fumarate (MDI BFF)","type":"EXPERIMENTAL"},{"label":"Symbicort Turbuhaler","type":"ACTIVE_COMPARATOR"}],"summary":"Study comparing the same drugs as a dual combination product (budesonide and formoterol) given via two different inhalers. To see which one results in the best effect on breathing.","primaryOutcome":{"measure":"Peak Change From Baseline in Forced Expiratory Volume in 1 Second (FEV1) Within 4 Hours Post-dose Following 1 Week of Treatment","timeFrame":"baseline and 4 hours post dose after 1 week of treatment","effectByArm":[{"arm":"BFF MDI","deltaMin":0.256,"sd":null},{"arm":"Symbicort Turbuhaler","deltaMin":0.274,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.3450"}]},"eligibility":{"minAge":"40 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":4,"countries":["Germany"]},"refs":{"pmids":["35815354"],"seeAlso":["https://filehosting-v2.pharmacm.com/api/Attachment/Download?tenantId=80217111&amp;parentIdentifier=D5980C00023&amp;attachmentIdentifier=f9e68af7-6312-4372-b1bf-35effeef648e&amp;fileName=d5980c00023-csp-v4_Redacted_(23-Nov-2021).pdf&amp;versionIdentifier=","https://filehosting-v2.pharmacm.com/api/Attachment/Download?tenantId=80217111&amp;parentIdentifier=D5980C00023&amp;attachmentIdentifier=9badafff-7cec-4872-a850-18a47ba8b760&amp;fileName=d5980C00023-sap-ed-2.1_Redacted_(23-Nov-2021).pdf&amp;versionIdentifier="]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":33},"commonTop":["Angina pectoris","Abdominal discomfort"]}}